200 related articles for article (PubMed ID: 10505421)
1. The effects of levosimendan on the left ventricular function and protein phosphorylation in post-ischemic guinea pig hearts.
Kristof E; Szigeti G; Papp Z; Bodi A; Ball NA; Walsh RA; Edes I
Basic Res Cardiol; 1999 Aug; 94(4):223-30. PubMed ID: 10505421
[TBL] [Abstract][Full Text] [Related]
2. Effects of Levosimendan, a cardiotonic agent targeted to troponin C, on cardiac function and on phosphorylation and Ca2+ sensitivity of cardiac myofibrils and sarcoplasmic reticulum in guinea pig heart.
Edes I; Kiss E; Kitada Y; Powers FM; Papp JG; Kranias EG; Solaro RJ
Circ Res; 1995 Jul; 77(1):107-13. PubMed ID: 7788868
[TBL] [Abstract][Full Text] [Related]
3. Effect of levosimendan on balance between ATP production and consumption in isolated perfused guinea-pig heart before ischemia or after reperfusion.
Eriksson O; Pollesello P; Haikala H
J Cardiovasc Pharmacol; 2004 Sep; 44(3):316-21. PubMed ID: 15475828
[TBL] [Abstract][Full Text] [Related]
4. Cardiotonic drugs differentially alter cytosolic [Ca2+] to left ventricular relationships before and after ischemia in isolated guinea pig hearts.
Chen Q; Camara AK; Rhodes SS; Riess ML; Novalija E; Stowe DF
Cardiovasc Res; 2003 Oct; 59(4):912-25. PubMed ID: 14553831
[TBL] [Abstract][Full Text] [Related]
5. The role of cAMP- and cGMP-dependent protein kinases in the cardiac actions of the new calcium sensitizer, levosimendan.
Haikala H; Kaheinen P; Levijoki J; Lindén IB
Cardiovasc Res; 1997 Jun; 34(3):536-46. PubMed ID: 9231037
[TBL] [Abstract][Full Text] [Related]
6. Systemic and coronary hemodynamic actions and left ventricular functional effects of levosimendan in conscious dogs.
Harkin CP; Pagel PS; Tessmer JP; Warltier DC
J Cardiovasc Pharmacol; 1995 Aug; 26(2):179-88. PubMed ID: 7475041
[TBL] [Abstract][Full Text] [Related]
7. Levosimendan: effects of a calcium sensitizer on function and arrhythmias and cyclic nucleotide levels during ischemia/reperfusion in the Langendorff-perfused guinea pig heart.
Du Toit EF; Muller CA; McCarthy J; Opie LH
J Pharmacol Exp Ther; 1999 Aug; 290(2):505-14. PubMed ID: 10411556
[TBL] [Abstract][Full Text] [Related]
8. ORM-3819 promotes cardiac contractility through Ca(2+) sensitization in combination with selective PDE III inhibition, a novel approach to inotropy.
Nagy L; Pollesello P; Haikala H; Végh Á; Sorsa T; Levijoki J; Szilágyi S; Édes I; Tóth A; Papp Z; Papp JG
Eur J Pharmacol; 2016 Mar; 775():120-9. PubMed ID: 26872993
[TBL] [Abstract][Full Text] [Related]
9. Calcium sensitization as new principle of inotropic therapy in end-stage heart failure?
Zimmermann N; Boknik P; Gams E; Herzig JW; Neumann J; Scholz H
Eur J Cardiothorac Surg; 1998 Jul; 14(1):70-5. PubMed ID: 9726618
[TBL] [Abstract][Full Text] [Related]
10. Effects of levosimendan on myocardial contractility and Ca2+ transients in aequorin-loaded right-ventricular papillary muscles and indo-1-loaded single ventricular cardiomyocytes of the rabbit.
Sato S; Talukder MA; Sugawara H; Sawada H; Endoh M
J Mol Cell Cardiol; 1998 Jun; 30(6):1115-28. PubMed ID: 9689586
[TBL] [Abstract][Full Text] [Related]
11. Effects of Combined Milrinone and Levosimendan Treatment on Systolic and Diastolic Function During Postischemic Myocardial Dysfunction in a Porcine Model.
Axelsson B; Häggmark S; Svenmarker S; Johansson G; Gupta A; Tydén H; Wouters P; Haney M
J Cardiovasc Pharmacol Ther; 2016 Sep; 21(5):495-503. PubMed ID: 26837238
[TBL] [Abstract][Full Text] [Related]
12. The cardiotonic effects of levosimendan in guinea pig hearts are modulated by beta-adrenergic stimulation.
Bódi A; Szilágyi S; Edes I; Papp Z
Gen Physiol Biophys; 2003 Sep; 22(3):313-27. PubMed ID: 14986883
[TBL] [Abstract][Full Text] [Related]
13. Effects of levosimendan and milrinone on oxygen consumption in isolated guinea-pig heart.
Kaheinen P; Pollesello P; Levijoki J; Haikala H
J Cardiovasc Pharmacol; 2004 Apr; 43(4):555-61. PubMed ID: 15085067
[TBL] [Abstract][Full Text] [Related]
14. Cardiac responses to calcium sensitizers and isoproterenol in intact guinea pig hearts. Effects on cyclic AMP levels, protein phosphorylation, myoplasmic calcium concentration, and left ventricular function.
Kristof E; Szigeti G; Papp Z; Bodi A; Facsko A; Kovacs L; Papp JG; Kranias EG; Edes I
Ann N Y Acad Sci; 1998 Sep; 853():316-9. PubMed ID: 10603968
[No Abstract] [Full Text] [Related]
15. Ca2+ sensitizer superior to catecholamine during myocardial stunning?
Meyer K; Klocke RC; Schipke JD; Gams E; Korbmacher B
Eur J Cardiothorac Surg; 2008 Aug; 34(2):326-31. PubMed ID: 18539040
[TBL] [Abstract][Full Text] [Related]
16. A quantitative comparison of functional and anti-ischaemic effects of the phosphodiesterase-inhibitors, amrinone, milrinone and levosimendan in rabbit isolated hearts.
Rump AF; Acar D; Klaus W
Br J Pharmacol; 1994 Jul; 112(3):757-62. PubMed ID: 7921599
[TBL] [Abstract][Full Text] [Related]
17. Comparison of enoximone, amrinone, or levosimendan enriched St. Thomas' hospital cardioplegic solutions used for myocardial preservation in isolated guinea pig hearts.
Köksal C; Süzer O; Bozkurt AK; Köseoğlu S
Acta Medica (Hradec Kralove); 2002; 45(3):93-7. PubMed ID: 12515045
[TBL] [Abstract][Full Text] [Related]
18. A role for the RISK pathway and K(ATP) channels in pre- and post-conditioning induced by levosimendan in the isolated guinea pig heart.
du Toit EF; Genis A; Opie LH; Pollesello P; Lochner A
Br J Pharmacol; 2008 May; 154(1):41-50. PubMed ID: 18297097
[TBL] [Abstract][Full Text] [Related]
19. Levosimendan (OR-1259), a myofilament calcium sensitizer, enhances myocardial contractility but does not alter isovolumic relaxation in conscious and anesthetized dogs.
Pagel PS; Harkin CP; Hettrick DA; Warltier DC
Anesthesiology; 1994 Oct; 81(4):974-87. PubMed ID: 7943849
[TBL] [Abstract][Full Text] [Related]
20. Effect of a calcium-sensitizing agent, levosimendan, on the postcardioplegic inotropic response of the myocardium.
Lochner A; Colesky F; Genade S
Cardiovasc Drugs Ther; 2000 Jun; 14(3):271-81. PubMed ID: 10935149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
